PTGX: Protagonist Therapeutics Inc
今日PTGX汇率已更改-3.26%。当日,交易品种以低点81.4700和高点84.5400进行交易。
关注Protagonist Therapeutics Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
PTGX新闻
- Protagonist Therapeutics, Inc. (PTGX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Alumis Stock Catapults More Than 110% As Biotech Takes On J&J, Protagonist In Psoriasis
- Truist上调Protagonist Therapeutics股票目标价至110美元,预计迎来关键一年
- Truist raises Protagonist Therapeutics stock price target to $110 on pivotal year ahead
- Chasing Bubbles And Riding Value In Another Year Leading The S&P 500
- Protagonist Therapeutics股价创93.53美元历史新高
- Protagonist Therapeutics stock hits all-time high at 93.53 USD
- Citizens维持Protagonist Therapeutics股票评级,引用rusfertide疗效
- Citizens maintains Protagonist Therapeutics stock rating, citing rusfertide efficacy
- Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3
- Jefferies维持Protagonist Therapeutics股票买入评级,看好其管线潜力
- Protagonist Therapeutics stock maintains Buy rating at Jefferies on pipeline potential
- Clear Street上调Protagonist Therapeutics目标价至91美元
- Protagonist Therapeutics stock price target raised to $91 at Clear Street
- Protagonist TherapeuticsQ3每股收益及营收超出预期
- Protagonist Therapeutics (PTGX) Reports Q3 Loss, Lags Revenue Estimates
- Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?
- Kymera Therapeutics, Inc. (KYMR) Reports Q3 Loss, Misses Revenue Estimates
- Protagonist Therapeutics (PTGX) Expected to Beat Earnings Estimates: Should You Buy?
- Truist Securities上调Protagonist Therapeutics股票目标价至88美元
- Truist Securities raises Protagonist Therapeutics stock price target to $88
- Regeneron (REGN) Q3 Earnings and Revenues Surpass Estimates
- Johnson & Johnson Q3 Earnings Surprise, Icotrokinra Shines Again (NYSE:JNJ)
- 强生公司计划将骨科业务分拆为独立实体
常见问题解答
PTGX股票今天的价格是多少?
Protagonist Therapeutics Inc股票今天的定价为81.9900。它在81.4700 - 84.5400范围内交易,昨天的收盘价为84.7500,交易量达到1688。PTGX的实时价格图表显示了这些更新。
Protagonist Therapeutics Inc股票是否支付股息?
Protagonist Therapeutics Inc目前的价值为81.9900。股息政策取决于公司,而投资者也会关注9.13%和USD。实时查看图表以跟踪PTGX走势。
如何购买PTGX股票?
您可以以81.9900的当前价格购买Protagonist Therapeutics Inc股票。订单通常设置在81.9900或81.9930附近,而1688和-2.98%显示市场活动。立即关注PTGX的实时图表更新。
如何投资PTGX股票?
投资Protagonist Therapeutics Inc需要考虑年度范围74.0250 - 96.5400和当前价格81.9900。许多人在以81.9900或81.9930下订单之前,会比较-5.26%和。实时查看PTGX价格图表,了解每日变化。
Protagonist Therapeutics Inc股票的最高价格是多少?
在过去一年中,Protagonist Therapeutics Inc的最高价格是96.5400。在74.0250 - 96.5400内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Protagonist Therapeutics Inc的绩效。
Protagonist Therapeutics Inc股票的最低价格是多少?
Protagonist Therapeutics Inc(PTGX)的最低价格为74.0250。将其与当前的81.9900和74.0250 - 96.5400进行比较,可以发现潜在的长期切入点。观看PTGX在图表上的实时走势以获取更多详细信息。
PTGX股票是什么时候拆分的?
Protagonist Therapeutics Inc历史上曾经历过股票拆分。这些变化在公司行动后的、84.7500和9.13%中可见。
- 前一天收盘价
- 84.7500
- 开盘价
- 84.5100
- 卖价
- 81.9900
- 买价
- 81.9930
- 最低价
- 81.4700
- 最高价
- 84.5400
- 交易量
- 1.688 K
- 日变化
- -3.26%
- 月变化
- -5.26%
- 6个月变化
- 9.13%
- 年变化
- 9.13%
- 实际值
- 预测值
- 前值